null

SMILES C[C@H]1CC[C@H](CN1C(=O)C=C)Nc1ncnc2[nH]ccc12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 209866   

TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.51E+3nMpH: 7.4 T: 2°CAssay Description:Test compounds were solubilized in dimethyl sulfoxide (DMSO) to a stock concentration of 30 mM. Compounds were diluted in DMSO to create an 11-point ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN94F8PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMpH: 7.4 T: 2°CAssay Description:Test compounds were solubilized in dimethyl sulfoxide (DMSO) to a stock concentration of 30 mM. Compounds were diluted in DMSO to create an 11-point ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN94F8PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human GST-tagged JAK2 using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25T3P53PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human GST-tagged cytoplasmic JAK2 catalytic domain (809 to 1153+9 residues) expressed in baculovirus expression system usin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2TX3JC2PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JAK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2930XJSPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human JAK2 assessed as phosphorylation level in presence of 1 mM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21V5JNKPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H1361PPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Pfizer Worldwide R&D

LigandPNGBDBM209866(PF-06651600 | US11111242, Example 5 | US2023034848...)copy SMILES
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails